Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 181 Next >>

Filter Applied: MRI (Click to remove)

Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012

Non-Paraneoplastic Limbic Encephalitis Characterized by Mesio-Temporal Seizures and Extratemporal Lesions: A Case Report
Seizure 19:446-449, Cianci,V.,et al, 2010

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies
Arch Neurol 58:225-230, Honorat,J.,et al, 2001

Autoantibodies to Glutamic Acid Decarboxylase in Three Patients With Cerebellar Ataxia, Late-Onset Insulin-Dependent Diabetes Mellitus, and Polyendocrine Autoimmunity
Neurol 49:1026-1030, Saiz,A.,et al, 1997

Autoimmune Encephalitis Misdiagnosis in Adults
JAMA Neurol 80:30-39, Flanagan,E.P.,et al, 2023

Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome
AJNR 39:824-829, Zhang, T.,et al, 2018

Paraneoplastic and Autoimmune Encephalitis
UptoDate July, Dalmau, J.,et al, 2017

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
Neurol 85:177-189, Wingerchuk, D.M.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

A Case of Hashimoto Encephalopathy Clinical Manifestation, Imaging, Pathology, Treatment, and Prognosis
The Neurologist 17:141-143, Zhao, W.,et al, 2011

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Eur J Neurol 18:19-27, Titulaer, M.J.,et al, 2011

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
Neurol 76:1858-1865, OConnor, P.W.,et al, 2011

Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011

Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011

Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011

Whipple Limbic Encephalitis
Arch Neurol 68:1471-1473, Blanc, F.,et al, 2011

Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Arch Neurol 67:118-121, Kurian,M.,et al, 2010

The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis
Neurol 74:857-859, Graus,F.,et al, 2010

Longitudinally Extensive Myelopathy in Caucasians: A West Australian Study of 26 Cases from the Perth Demyelinating Diseases Database
JNNP 81:209-212, Qiu,W.,et al, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

A Case of Neurosarcoidosis Successfully Treated with Rituximab
Neurol 75:568-570, Bomprezzi,R., et al, 2010

Clinical Reasoning: A 9-year-old Girl With Seizures and Encephalopathy
Neurol 74:e97-e100, Nguyen,T.P. &El-Hakam,L.M., 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Clinicopath Conf, Neurosarcoidosis
NEJM 360:802-809, Case 6-2009, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Lyme Neuroborreliosis: Manifestations of a Rapidly Emerging Zoonosis
AJNR 30:1079-1087, Hildenbrand,P.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Paraneoplastic Extra Limbic Encephalitis Associated with Thymoma
ICVTS 9:755-756, Rizzardi,G.,et al, 2009

Reversible Extralimbic Paraneoplastic Encephalopathies with Large Abnormalities on Magnetic Resonance Images
Arch Neurol 66:268-271, McKeon,A.,et al, 2009

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

The Varicella Zoster Virus Vasculopathies: Clinical, CSF, Imaging, and Virologic Features
Neurol 70:853-860, Nagel,M.A.,et al, 2008

Treatment-Responsive Subacute Limbic Encephalitis and NMDA Receptor Antibodies in a Man
Neurol 70:728-729, Novillo-Lopez,M.E.,et al, 2008

Diagnostic Approaches to Imported Schistosomal Myeloradiculopathy in Travelers
Neurol 71:66-67, Makinson,A.,et al, 2008



Showing articles 0 to 50 of 181 Next >>